Incidence and prevalence of neuromyelitis optica spectrum disorders in Slovakia

被引:4
|
作者
Szilasiova, Jarmila [1 ]
Gazda, Jakub [2 ]
Cimprichova, Andrea [3 ]
Cvengrosova, Anna [4 ]
Donath, Vladimir [5 ]
Fedicova, Miriam [6 ]
Gurcik, Ladislav [7 ]
Hancinova, Viera [8 ]
Jurcaga, Frantisek [9 ]
Kahancova, Edita [6 ]
Kantorova, Ema [10 ]
Karlik, Martin [11 ]
Klimova, Eleonora [4 ]
Kovacova, Slavomira [12 ]
Krastev, Georgi [13 ]
Megova, Andrea [14 ]
Michalik, Jozef [10 ]
Mikula, Pavol [15 ]
Snopekova, Lubica [16 ]
Stevkova, Zuzana [13 ]
机构
[1] Pavol Jozef Safarik Univ, Dept Neurol, Kosice, Slovakia
[2] Pavol Jozef Safarik Univ, Dept Internal Med 2, Kosice, Slovakia
[3] Fac Hosp, Dept Neurol, Trencin, Slovakia
[4] JA Reiman Fac Hosp, Dept Neurol, Presov, Slovakia
[5] FD Roosevelt Fac Hosp, Dept Neurol, Banska Bystrica, Slovakia
[6] L Pasteur Univ Hosp, Dept Neurol, Kosice, Slovakia
[7] AGEL Hosp, Dept Neurol, Levoca, Slovakia
[8] Univ Hosp, Dept Neurol, Bratislava Ruzinov, Slovakia
[9] St Michal Univ Hosp, Dept Neurol, Bratislava, Slovakia
[10] Univ Hosp, Dept Neurol, Martin, Slovakia
[11] L Derer Univ Hosp Bratislava, Dept Neurol, Bratislava, Slovakia
[12] Fac Hosp, Dept Neurol, Nitra, Slovakia
[13] Fac Hosp, Dept Neurol, Trnava, Slovakia
[14] Univ Hosp, Dept Neurol, Bratislava, Slovakia
[15] Pavol Jozef Safarik Univ, Dept Social & Behav Med, Kosice, Slovakia
[16] Hosp Poprad, Dept Neurol, Poprad, Slovakia
关键词
Neuromyelitis optica spectrum disorders; AQP4; incidence; prevalence; Slovakia population-based study; CLINICAL-FEATURES; DIAGNOSTIC-CRITERIA;
D O I
10.1080/01616412.2021.1952741
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective : Neuromyelitis optica spectrum disorders (NMOSDs) are a group of rare, inflammatory, demyelinating diseases that affect the central nervous system. Neither the incidence nor the prevalence of NMOSD has been determined in Slovakia thus far. The aim of this study was to determine both the incidence and the prevalence of NMOSD in Slovakia using the 2015 International Panel of NMOSD diagnosis (IPND) criteria. Methods : We performed a population-based study in Slovakia to estimate both the incidence and the prevalence of NMOSD during the period from 1 January 2006 through 31 December 2019. NMOSD cases were reported from multiple sources and the diagnosis was subsequently verified using the IPND criteria by a joint commitee of three neurologists. The prevalence is reported as number of cases per 100,000 inhabitans and the incidence as number of new cases per 1,000,000 person-years. Age-adjusted rates to the WHO standard population 2005-2025 were also calculated. Results : We identified 63 NMOSD cases. The crude point-prevalence rate was 1.37 (95% CI 1.03-1.71) per 100,000 inhabitants. The crude indidence rate was 0.88 (95% CI 0.65-1.12) per 1,000,000 person-years. The age-adjusted point-prevalence rate was 1.42 (95% CI 1.07-1.84) per 100,000 persons and the age-adjusted incidence rate was 0.96 (95% CI 0.72-1.25) per 1,000,000 person-years. Conclusion : The NMOSD epidemiological situation in Slovakia is comparable to those reported from other Caucasian populations.
引用
收藏
页码:38 / 46
页数:9
相关论文
共 50 条
  • [41] Therapeutic options in neuromyelitis optica spectrum disorders
    Kitley, Joanna
    Palace, Jackie
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (03) : 319 - 329
  • [42] Pathologic yawning in neuromyelitis optica spectrum disorders
    Lana-Peixoto, Marco A.
    Callegaro, Dagoberto
    Talim, Natlia
    Talim, Livia E.
    Pereira, Samira A.
    Campos, Gilberto Belisario
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (04) : 527 - 532
  • [43] Early treatment in neuromyelitis optica spectrum disorders
    Radaelli, M.
    Sangalli, F.
    Guerrieri, S.
    Moiola, L.
    Esposito, F.
    Colombo, B.
    Romeo, M.
    Preziosa, P.
    Pensato, U.
    Greco, G.
    Comola, M.
    Comi, G.
    Martinelli, V.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 130 - 130
  • [44] Treatment of relapses in neuromyelitis optica spectrum disorders
    Hradilek, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 : S58 - S61
  • [45] Treatment of neuromyelitis optica spectrum disorders with azathioprine
    Lin, C. R.
    Tan, K.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S207 - S207
  • [46] A novel autoantigen in neuromyelitis optica spectrum disorders
    Tzartos, J. S.
    Stergiou, C.
    Kilintireas, K.
    Zisimopoulou, P.
    Thomaidis, T.
    Tzartos, S. J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 510 - 510
  • [47] Differential diagnosis of neuromyelitis optica spectrum disorders
    Kim, Sung-Min
    Kim, Seong-Joon
    Lee, Haeng Jin
    Kuroda, Hiroshi
    Palace, Jacqueline
    Fujihara, Kazuo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (07) : 265 - 289
  • [48] Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
    Ringelstein, Marius
    Asseyer, Susanna
    Lindenblatt, Gero
    Fischer, Katinka
    Pul, Refik
    Skuljec, Jelena
    Revie, Lisa
    Giglhuber, Katrin
    Haeussler, Vivien
    Karenfort, Michael
    Hellwig, Kerstin
    Paul, Friedemann
    Bellmann-Strobl, Judith
    Otto, Carolin
    Ruprecht, Klemens
    Ziemssen, Tjalf
    Emmer, Alexander
    Rothhammer, Veit
    Nickel, Florian T.
    Angstwurm, Klemens
    Linker, Ralf
    Laurent, Sarah A.
    Warnke, Clemens
    Jarius, Sven
    Korporal-Kuhnke, Mirjam
    Wildemann, Brigitte
    Wolff, Stephanie
    Seipelt, Maria
    Yalachkov, Yavor
    Retzlaff, Nele
    Zettl, Uwe K.
    Rommer, Paulus S.
    Kowarik, Markus C.
    Wickel, Jonathan
    Geis, Christian
    Huemmert, Martin W.
    Trebst, Corinna
    Senel, Makbule
    Gold, Ralf
    Klotz, Luisa
    Kleinschnitz, Christoph
    Meuth, Sven G.
    Aktas, Orhan
    Berthele, Achim
    Ayzenberg, Ilya
    NEUROLOGY, 2024, 103 (09)
  • [49] Neuromyelitis optica spectrum disorders - unexpected, overlooked
    Mellebeek, E.
    Van Asbroeck, P. J.
    Van Boxstael, S.
    Van Bylen, B.
    Mesotten, D.
    Boer, W.
    Vundelinckx, J.
    Van Poucke, S.
    Haesendonck, R.
    Vanderlaenen, M.
    Fivez, T.
    Van Zundert, J.
    Vanelderen, P.
    ACTA CLINICA BELGICA, 2020, 75 : 31 - 32
  • [50] Neuromyelitis optica spectrum disorders - laboratory examination
    Nytrova, P.
    Kral, V
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 : S31 - S36